OpenURL Connection Search

Select item for more details and to access through your institution.

Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 485, doi. 10.1111/apt.14419
By:
- Tadbiri, S.;
- Peyrin‐Biroulet, L.;
- Serrero, M.;
- Filippi, J.;
- Pariente, B.;
- Roblin, X.;
- Buisson, A.;
- Stefanescu, C.;
- Trang‐Poisson, C.;
- Altwegg, R.;
- Marteau, P.;
- Vaysse, T.;
- Bourrier, A.;
- Nancey, S.;
- Laharie, D.;
- Allez, M.;
- Savoye, G.;
- Gilletta, C.;
- Gagniere, C.;
- Vuitton, L.
Publication type:
Article
Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1077, doi. 10.1111/apt.14371
By:
- Martineau, C.;
- Flourié, B.;
- Wils, P.;
- Vaysse, T.;
- Altwegg, R.;
- Buisson, A.;
- Amiot, A.;
- Pineton de Chambrun, G.;
- Abitbol, V.;
- Fumery, M.;
- Hébuterne, X.;
- Viennot, S.;
- Laharie, D.;
- Beaugerie, L.;
- Nancey, S.;
- Sokol, H.;
- Abitbol, Vered;
- Altwegg, Romain;
- Amiot, Aurélien;
- Beaugerie, Laurent
Publication type:
Article
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 3, p. 310, doi. 10.1111/apt.14167
By:
- Amiot, A.;
- Serrero, M.;
- Peyrin‐Biroulet, L.;
- Filippi, J.;
- Pariente, B.;
- Roblin, X.;
- Buisson, A.;
- Stefanescu, C.;
- Trang‐Poisson, C.;
- Altwegg, R.;
- Marteau, P.;
- Vaysse, T.;
- Bourrier, A.;
- Nancey, S.;
- Laharie, D.;
- Allez, M.;
- Savoye, G.;
- Moreau, J.;
- Vuitton, L.;
- Viennot, S.
Publication type:
Article

Found: 3

Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort.

Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study.

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.